Ashton Thomas Securities’s Pfizer PFE Stock Holding History

Ashton Thomas Securities’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,123	Closed	-$229K	–	478
2026 Q1	$229K	Buy	+8,123	New	+$216K	0.03%	337
2024 Q4	–	Sell	-6,843	Closed	-$198K	–	962
2024 Q3	$198K	Buy	+6,843	New	+$200K	0.04%	266

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ashton Thomas Securities's PFE Position: Q2 2026 in Review

Ashton Thomas Securities sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,123 shares — an estimated $229K sold.

Ashton Thomas Securities first reported a position in PFE in Q3 2024 and held it in 2 quarters. The position peaked at $229K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Ashton Thomas Securities reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Ashton Thomas Securities sold 8,123 Pfizer shares in Q2 2026, an estimated $229K.
Ashton Thomas Securities first reported a position in Pfizer in Q3 2024 and held it in 2 quarters.
Ashton Thomas Securities's Pfizer position peaked at $229K in Q1 2026.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.